0000905148-20-000827.txt : 20200721
0000905148-20-000827.hdr.sgml : 20200721
20200721212911
ACCESSION NUMBER: 0000905148-20-000827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200721
FILED AS OF DATE: 20200721
DATE AS OF CHANGE: 20200721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, Ltd.
CENTRAL INDEX KEY: 0001770835
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040093
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic Fund II L.P.
CENTRAL INDEX KEY: 0001634632
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040094
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, L.P.
CENTRAL INDEX KEY: 0001770834
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040095
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP II, L.P.
CENTRAL INDEX KEY: 0001729409
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040096
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP II, Ltd.
CENTRAL INDEX KEY: 0001729408
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040097
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adelman Robert J
CENTRAL INDEX KEY: 0001329161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040098
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic Fund, L.P.
CENTRAL INDEX KEY: 0001504130
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 201040099
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
form4.xml
X0306
4
2020-07-21
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001329161
Adelman Robert J
1700 OWENS STREET
SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001504130
venBio Global Strategic Fund, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001770835
venBio Global Strategic GP, Ltd.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001634632
venBio Global Strategic Fund II L.P.
1700 OWENS STREET
SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001770834
venBio Global Strategic GP, L.P.
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001729409
venBio Global Strategic GP II, L.P.
1700 OWENS STREET
SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
0001729408
venBio Global Strategic GP II, Ltd.
1700 OWENS STREET
SUITE 595
SAN FRANCISCO
CA
94158
true
true
See Remarks
Common Stock
2020-07-21
4
C
0
78175
A
96406
D
Common Stock
2020-07-21
4
C
0
3100020
A
3969789
I
See footnote
Common Stock
2020-07-21
4
C
0
3941949
A
4418325
I
See footnote
Common Stock
2020-07-21
4
P
0
850000
19
A
5268325
I
See footnote
Common Stock
2020-07-21
4
P
0
3000
19
A
99406
D
Common Stock
461811
I
See footnotes
Series A Convertible Preferred Stock
2020-07-21
4
C
0
78175
D
Common Stock
78175
0
D
Series A Convertible Preferred Stock
2020-07-21
4
C
0
3100020
D
Common Stock
3100020
0
I
See footnote
Series A Convertible Preferred Stock
2020-07-21
4
C
0
2398588
D
Common Stock
2398588
0
I
See footnote
Series B Convertible Preferred Stock
2020-07-21
4
C
0
490411
D
Common Stock
490411
0
I
See footnote
Series C Convertible Preferred Stock
2020-07-16
4
C
0
1052950
D
Common Stock
1052950
0
I
See footnote
The shares are held by venBio Global Strategic Fund, L.P. venBio Global Strategic GP, L.P. is the general partner of venBio Global Strategic Fund, L.P. and venBio Global Strategic GP, Ltd. is the general partner of venBio Global Strategic GP, L.P. Robert Adelman is a director of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd. and Mr. Adelman disclaims beneficial ownership of such securities, except to the extent of its/his indirect pecuniary interest therein.
The shares are held by venBio SPV, LLC, which is wholly-owned by venBio Global Strategic Fund, L.P. Robert Adelman is a managing director of venBio SPV, LLC and disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
Includes 869,618 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Includes 476,376 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
The shares are held by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. Robert Adelman is a director of venBio Global Strategic GP II, Ltd. Each of venBio Global Strategic GP II, LP, venBio Global Strategic GP II, Ltd, and Mr. Adelman disclaims beneficial ownership of such securities, except to the extent of its/his indirect pecuniary interest therein.
The shares are held by Robert Adelman directly.
Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Includes 18,231 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
venBio Global Strategic Fund, L.P., by: venBio Global Strategic GP, L.P., its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
2020-07-21
venBio Global Strategic GP, L.P., by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ David Pezeshki as attorney-in-fact
2020-07-21
venBio Global Strategic GP, Ltd., by: /s/ David Pezeshki, as attorney-in-fact
2020-07-21
venBio Global Strategic Fund II, L.P., by: venBio Global Strategic GP II, L.P., its general partner, by: venBio Global Strategic GP II, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
2020-07-21
venBio Global Strategic GP II, L.P., by: venBio Global Strategic GP II, Ltd., its general partner, by: /s/ David Pezeshki as attorney-in-fact
2020-07-21
venBio Global Strategic GP II, Ltd., by: /s/ David Pezeshki, as attorney-in-fact
2020-07-21
Robert Adelman, by: /s/ David Pezeshki, as attorney-in-fact
2020-07-21